Peptide Research

Peptides are becoming increasingly popular in research, skincare, and wellness science - but most people don't actually know how peptides are made. Here's a simple, beginner-friendly breakdown of the process, from raw materials to finished research peptides.

Retatrutide (GLP-3) is not simply a weight loss drug - it may be the most powerful disease-modifying therapy in the history of metabolic medicine. As a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, it represents a fundamentally different pharmacological approach compared to semaglutide or tirzepatide.

GLP-1 agonists represent a cornerstone of modern pharmacotherapy for type 2 diabetes mellitus and obesity management. Key trials like STEP, SURPASS, and SELECT have demonstrated efficacy in glycemic control (HbA1c reductions of 1.0–2.0%), weight loss (10–20% mean body weight reduction), and cardiovascular risk reduction. Investigational uses in heart failure, NASH, and neurodegeneration are currently being explored.

AOD9604 is a synthetic peptide derived from the C-terminal fragment of human growth hormone, designed to mimic the lipolytic properties of hGH without its anabolic or hyperglycemic effects. Developed initially for potential applications in obesity and fat metabolism, human clinical data remain limited, with no FDA approval for any indication as of 2026.

Peptides for muscle growth have gained significant attention as alternatives to anabolic steroids for enhancing hypertrophy, recovery, and performance. This review synthesizes peer-reviewed evidence from 2020–2026, focusing on GH-releasing peptides (GHRPs) like ipamorelin and CJC-1295, and myostatin inhibitors like follistatin. No peptide is FDA-approved for muscle growth or athletic performance enhancement.

BPC-157 (Body Protective Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It has demonstrated significant effects on wound healing, tendon and ligament repair, and neuroprotection in preclinical models. Research indicates modulation of growth hormone receptors, nitric oxide synthesis, and angiogenesis pathways.

Epithalon (Epitalon) is a synthetic tetrapeptide studied extensively for its role in telomere elongation and anti-aging effects. Research by Professor Vladimir Khavinson demonstrates its ability to activate telomerase, an enzyme critical for maintaining telomere length. Studies in cell cultures and animal models show promising results in extending cellular lifespan.

SS-31 (Elamipretide) is a mitochondria-targeted peptide that selectively concentrates in the inner mitochondrial membrane. Research indicates it stabilises cardiolipin, a critical phospholipid for mitochondrial function, thereby improving ATP production and reducing reactive oxygen species. Studies show potential applications in heart failure, kidney disease, and age-related conditions.